The Wall Street Journal
Showcase: Gene-Editing Disease
Go inside Alex Marson's lab at UCSF, where he and his team are testing treatments using gene-editing tool Crispr to rewrite parts of DNA and cure disease.
Curated Video
University of Alberta team sequencing tree genomes to find what makes forests resilient to climate change
A team of researchers at the University of Alberta are sequencing the genome of trees to figure out why some trees are resilient when faced with climate change. The Genome Alberta Resilient Forests project is sequencing the genomes for...
Curated Video
New 'Pangenome' project reveals diverse look at human DNA
Factoring in diversity.. how scientists are improving the map of the human genome.
Bloomberg
Illumina CEO Thaysen on Nvidia Partnership, Genomics, M&A
Illumina CEO Jacob Thaysen discusses the outlook for genomics and the company's partnership with Nvidia. He speaks with Katherine Greifeld at the JPMorgan Health-Care Conference in San Francisco.
Bloomberg
Anne Wojcicki on Ancestry, Health and the Human Genome
23andMe CEO and co-founder Anne Wojcicki talks about partnering with Amazon for Prime Day and the health benefits of understanding the human genome for consumers. She speaks with Bloomberg's Ed Ludlow in Sun Valley, Idaho.
Bloomberg
Your DNA Is Probably Out There, Like It or Not
Mar.02 -- Police around the U.S. have embraced "genetic genealogy," which uses DNA consumers offer up to the internet to identify criminal suspects. The method has helped solve rapes and murders dating back to the 1970s. But a key facet...
Curated Video
USA: HUMAN GENETIC PATTERN DECODING PROJECT
English/Nat
The United States and Britain on Tuesday agreed to openly share data from a groundbreaking project to decode the human genetic pattern.
It's a study that could serve as the foundation for developing new medical cures and...
Bloomberg
Illumina, Invesco Execs on Investing in Innovation
Oct.05 -- Alex Aravanis, Chief Technology Officer, Illumina and Nick Kalivas, Head of Factor and Core Equity Product Strategy, Invesco speak with Bloomberg’s Naomi Nix at the Bloomberg Invest Global Summit about investing in innovation.
Bloomberg
The US Has Fallen Far Behind in Genomics: Wojcicki
Anne Wojcicki, 23andMe CEO and co-founder, says the US has fallen far behind the UK and China when it comes to genomics. She's on "The David Rubenstein Show: Peer-to-Peer Conversations." This was recorded on July 21 in Palo Alto.
Curated Video
USA/UK: GENETICS: CLINTON/BLAIR
English/Nat
U-S President Bill Clinton and British Prime Minister Tony Blair are among those hailing Monday's announcement that a map of the human genome has been essentially completed.
A turning point in history was reached as...
Bloomberg
Moderna Sharing Less Data Since IPO, CEO Says
May.13 -- Moderna Inc. Chief Executive Officer Stephane Bancel discusses the biotech firm's recent initial public offering and pharmaceuticals development path on "Bloomberg Technology."
Bloomberg
If You're Not Learning at a Job: Quit, Says Wojcicki
Anne Wojcicki, 23andMe CEO and co-founder, shares some career advice and talks about whether or not she would leave her company for a government job. She's on "The David Rubenstein Show: Peer-to-Peer Conversations." This was recorded...
Curated Video
USA: WHITE HOUSE SPOKESMAN SHARIF PRESS BRIEFING
English/Nat
The White House has urged Pakistan to allow deposed Pakistani Prime Minister Nawaz Sharif to appeal his hijacking and terrorism conviction without impediment.
Sharif was sentenced to life imprisonment, on charges that he...
Bloomberg
NIH Director Says He Took the Bus to Meet Trump
Sep.06 -- Francis Collins, director of the National Institutes of Health, discusses meeting President-elect Trump at Trump Tower. He speaks to David Rubenstein on "The David Rubenstein Show: Peer-to-Peer Conversations."
Bloomberg
Hutchmed CEO on China's Biotech Sector Outlook
Hutchmed CEO Christian Hogg, discusses the outlook for China's Biotech industry and his company's business strategy. Hutchmed is a cancer drug developer backed by billionaire Li Ka-shing. He spoke with Haslinda Amin and Rishaad Salamat...
Bloomberg
We Can Save and Change Lives, Says Wojcicki
Anne Wojcicki, 23andMe CEO and co-founder, talks about how her company can help decipher the human genetic code and save lives. She's on "The David Rubenstein Show: Peer-to-Peer Conversations." This was recorded July 21 in Palo Alto.
Bloomberg
Branson Backs 23andMe Going Public
Anne Wojcicki, 23andMe CEO and co-founder, talks about going public via SPAC and being supported by Richard Branson. She's on "The David Rubenstein Show: Peer-to-Peer Conversations." This was recorded July 21st in Palo Alto.
Bloomberg
Tesla Still Undervalued: Ark Investment Management CEO
Jan.31 -- Cathie Wood, Ark Investment Management Founder & CEO, maintains her bullish case for Tesla and speaks about the struggles traditional auto manufacturers will have adjusting to succeed in the electric vehicle market. She speaks...
Bloomberg
Wojcicki, Branson on 23andMe Going Public Via SPAC
Feb.04 -- 23andMe Inc. Chief Executive Officer Anne Wojcicki and billionaire Richard Branson explain why the DNA-testing company entered into a deal to merge with VG Acquisition Corp., a special purpose acquisition company (SPAC) founded...
Bloomberg
How Does 23andMe Get So Much Information From Spit?
Anne Wojcicki, 23andMe CEO and co-founder, talks about how they get so much DNA information from one person's vial of saliva. She's on "The David Rubenstein Show: Peer-to-Peer Conversations." This was recorded on July 21 in Palo Alto.
Bloomberg
23andMe Gives Customers Plenty of Surprises
Anne Wojcicki, 23andMe CEO and co-founder, talks about the reactions customers have when they get their DNA test results back. She's on "The David Rubenstein Show: Peer-to-Peer Conversations." This was recorded on July 21 in Palo Alto.
Bloomberg
Can the Human Genome Be Built in a Lab?
June 3 -- Bloomberg View's Faye Flam discusses the scientific efforts to create a synthetic version of the human genetic code in a lab. She speaks with Bloomberg's Emily Chang on "Bloomberg West."
Bloomberg
How the Human Genome Project Transformed Medicine
Sep.06 -- Francis Collins, director of the National Institutes of Health, explains how mapping the human genetic code has advanced medicine. He speaks to David Rubenstein on "The David Rubenstein Show: Peer-to-Peer Conversations."
Bloomberg
Why Invest in Moonshots?
July 13 -- Andrew Hessel, distinguished research scientist at Autodesk, and Ethan Kurzweil, a Bessemer Venture Partners partner, discuss investing in moonshots with Bloomberg's Emily Chang on "Bloomberg West."